Syl-max Pharm Care, Inc.
Pharmacy
375 W Street Rd, Warminster
Pennsylvania, 18974-3218
215-956-9280 215-956-2320
Syl-max Pharm Care, Inc. is a Pharmacy in Warminster, Pennsylvania. It is located at 375 W Street Rd, Warminster and it's customer support contact number is 215-956-9280. The authorized person of Syl-max Pharm Care, Inc. is Harry T. Lipschultz, R.PH. who is President of the pharmacy and his contact number is 215-956-9280. Active license number of Syl-max Pharm Care, Inc. is PP481340 for Pharmacy in Pennsylvania. Syl-max Pharm Care, Inc. accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Syl-max Pharm Care, Inc. is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Syl-max Pharm Care, Inc. type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Syl-max Pharm Care, Inc. |
| Type: | Pharmacy |
| Location: | 375 W Street Rd, Warminster,
Pennsylvania, 18974-3218 |
| Phone: | 215-956-9280 |
| Fax: | 215-956-2320 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Harry T. Lipschultz |
| Credentials: | R.PH. |
| Position: | President |
| Contact Number: | 215-956-9280 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1073547022 |
| NPI Enumeration Date: | 10 Jul, 2006 |
| NPI Last Update On: | 20 Aug, 2015 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Syl-max Pharm Care, Inc. are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacy | PP481340 | Pennsylvania | Primary | |
| Pharmacist | RP035386L | Pennsylvania | Secondary | |
| Community/Retail Pharmacy | PP481340 | Pennsylvania | Secondary | |
| Long Term Care Pharmacy | PP481340 | Pennsylvania | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 1008952070001 | Medicaid | Pennsylvania | |
Medicare Enrollment:
Syl-max Pharm Care, Inc. is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 9335101484 | O20041101000363 | Syl-max Pharm Care, Inc. | PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY) |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 375 W Street Rd,
Warminster, Pennsylvania |
| Zip: | 18974-3218 |
| Phone Number: | 215-956-9280 |
| Fax Number: | 215-956-2320 |
Patients can reach Syl-max Pharm Care, Inc. at
375 W Street Rd, Warminster, Pennsylvania or can
call on customer care at 215-956-9280.
Comments/ Reviews:
Read all the reviews posted for Syl-max Pharm Care, Inc. below. You may also share your own experience with Syl-max Pharm Care, Inc.. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.